Radiotherapy Market Growth Set to Surge Significantly by
2030

Radiotherapy Market research
report by Delvens focuses on primary sections such as – market segments, market
outlook, competitive landscape, and company profiles. The segments provide
details in terms of various perspectives such as end-use industry, product or
service type, and any other relevant segmentation as per the market’s current
scenario which includes various aspects to perform further marketing activity. Radiotherapy
Market size was estimated at USD 6,900.0 million in 2023 and is projected to
reach USD 10,443.7 million in 2030 at a CAGR of 6.10% during the forecast to
2030.

Get Free Sample
Report: https://www.delvens.com/get-free-sample/radiotherapy-market

Radiotherapy works by damaging the DNA within targeted cancer
cells, preventing them from growing and dividing. There are two main types:
external beam radiotherapy, where radiation is delivered from outside the body,
and internal radiotherapy (or brachytherapy), where radioactive material is
placed directly inside or very close to the tumour. Radiotherapy can be used to
treat both localized tumours and those that have spread to other parts of the
body, depending on the cancer type and stage.

North America to
Dominate the Market

·       
In 2023, North
America held the largest share of the radiation oncology market, accounting for
45.52% of the revenue. This dominance can be attributed to supportive
government initiatives and the widespread availability of advanced radiotherapy
equipment. Additionally, the active involvement of key players in expanding
their market presence in the region is driving further growth.

·       
The Asia Pacific region is projected to be the
fastest-growing market during the forecast period, driven by advancements in
healthcare infrastructure, increased patient awareness, and significant unmet
healthcare needs. Additionally, the rising cancer burden and growing financial
support for key players in the region are expected to create lucrative growth
opportunities.

Recent Developments: Radiotherapy Market

·       
In
October 2023, Accuracy Incorporated achieved a major milestone with the
approval of their Tomo C radiation therapy system by the Chinese National
Medical Products Administration (NMPA). This approval underscores the company’s
dedication to expanding its market footprint and meeting the increasing demand
for cutting-edge radiation oncology technologies in China. It represents a
significant step in Accuracy’s ongoing efforts to strengthen its presence in
the global radiation therapy landscape.

·       
In July 2023,
IBA took a collaborative approach in India by forming a partnership with the
Apollo Proton Cancer Centre (APCC). The goal of this partnership was to provide
specialized training sessions for oncologists, focusing on proton beam therapy.
This initiative emphasizes IBA’s commitment to fostering knowledge sharing and
professional development within the field of radiation oncology, aiming to
enhance the skills of healthcare professionals and improve patient care in
India.

·       
In June
2023, PharmaLogic Holdings Corp. made a strategic move by signing a Master
Services Agreement aimed at the development and production of theragnostic
candidates VMT-01 and VMT-NET. These radiopharmaceuticals are being researched
for their potential in treating metastatic melanoma and neuroendocrine cancers.
The company’s ongoing research efforts reflect its dedication to advancing both
diagnostic and therapeutic solutions in radiation oncology, highlighting its
role in pushing the boundaries of cancer treatment.

The prominent players
in the Radiotherapy Market are

·       
Siemens healthineers gmbh (varian medical
systems, inc.)

·       
Elekta

·       
Accuray incorporated

·       
Iba worldwide (ion beam applications sa)

·       
Viewray technologies, inc.

·       
Perspective therapeutics, inc.

·       
Hitachi ltd.

·       
Sumitomo heavy industries ltd.

·       
Carl zeiss meditec ag

·       
Mim software inc.

·       
Panacea medical technologies pvt. Ltd.

·       
Provision healthcare

·       
Mevion medical systems

·       
Optivus proton therapy, inc.

·       
P-cure

·       
Intraop medical, inc.

·       
Bebig medical

·       
Koninklijke philips n.v. and More

Access Full Report: https://www.delvens.com/report/radiotherapy-market

In addition to the
market data for the Radiotherapy Market, Delvens offers client-centric reports
customized according to the company’s specific demand and requirements.

Frequently Asked
Questions

·       
What are the years considered to study
Radiotherapy Market intelligence report?

·       
What is the compound annual growth rate (CAGR)
of the Radiotherapy Market?

·       
Which region holds the largest market share in
Radiotherapy Market?

·       
Which region is the fastest growing in
Radiotherapy Market?

·       
Who are the major players in Radiotherapy
Market?

About Us:

Delvens is a strategic advisory and consulting company
headquartered in New Delhi, India. The company holds expertise in providing
syndicated research reports, customized research reports and consulting
services. Delvens qualitative and quantitative data is highly utilized by each
level from niche to major markets, serving more than 1K prominent companies by
assuring to provide the information on country, regional and global business
environment. We have a database for more than 45 industries in more than 115+
major countries globally.

Delvens database assists the clients by providing in-depth
information in crucial business decisions. Delvens offers significant facts and
figures across various industries namely Healthcare, IT & Telecom,
Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical,
Consumer Goods & Services, Food & Beverages. Our company provides an
exhaustive and comprehensive understanding of the business environment.

Contact us:

Unit No. 01, 3rd Floor, Plot No. 56, Block B

Sector 2 Noida, Near Noida Sector 15 Metro Station 201301,
IN

+44 20 3290 6466

+0120- 4903958

sales@delvens.com